LRRK2 and Parkinson disease: Several LRRK2 variants have been shown to enhance kinase activity (73), consistent with a toxic gain-of-function mechanism, and increased LRRK2 activity has also been implicated in postmortem brain tissue from idiopathic PD cases lacking LRRK2 mutations (133).